Form SC 13G Evolus, Inc. Filed by: Daewoong Pharmaceutical Co., Ltd.

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

  NAMES OF REPORTING PERSONS

   Daewoong Pharmaceutical Co., Ltd.

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

  (a)  ☐        (b)  ☐

  SEC USE ONLY

  CITIZENSHIP OR PLACE OF ORGANIZATION

   Republic of Korea

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

  SOLE VOTING POWER

  3,136,869 (1)

  SHARED VOTING POWER

  0

  SOLE DISPOSITIVE POWER

  3,136,869 (1)

  SHARED DISPOSITIVE POWER

  0

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

  3,136,869

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)

  ☐

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

  7.2% (2)

  TYPE OF REPORTING PERSON (See Instructions)

  CO

As part of a Convertible Promissory Note Conversion Agreement, dated March 23, 2021, by and between Evolus, Inc. (the “Issuer”) and Daewoong Pharmaceutical Co., Ltd. (the “Reporting Person”), the Reporting Person, among other things, agreed to convert its Convertible Promissory Note, dated July 30, 2020, issued by the Issuer in the initial principal amount of $40,000,000, including accrued and unpaid interest thereon, into 3,136,869 shares of the Issuer’s common stock, par value $0.00001 per share (the “Common Stock”), on March 25, 2021.

Percent of class is calculated based on 43,733,316 shares of Common Stock of the Issuer, which is the total number of shares outstanding on March 25, 2021 as reported in the Issuer’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 25, 2021.

Name of Issuer:

Address of Issuer’s Principal Executive Offices:

Name of Person Filing:

Address of Principal Business Office for All Reporting Persons:

Citizenship:

Title of Class of Securities:

CUSIP Number:

If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

Ownership

Amount Beneficially Owned:

Percent of Class:

Number of shares as to which such person has:

Ownership of Five Percent or Less of a Class.

Ownership of more than Five Percent on Behalf of Another Person.

Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person.

Identification and classification of members of the group.

Notice of Dissolution of Group.

Certifications.